REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment managers on Form 13F…

REPEAT – Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment managers on Form 13F filed with the Securities and Exchange Commission (SEC). As reported on March 31, 2025, institutional ownership […] The post REPEAT – Tevogen Sees Significant Institutional Owner…

Major Funds Pour Into Tevogen: BlackRock and Vanguard Lead 151% Stake Increase in Biotech Innovation

New SEC filings reveal 73% of institutional holders increased positions in Tevogen. Learn why major funds are backing this biotech's AI and manufacturing expansion. Get insights.